Puma Biotechnology, Inc.'s (NASDAQ:PBYI) US$24m market value fall may be overlooked by institutional investors after a year of 1.6% returns - Simply Wall St News
![Puma Biotech Stock Struggles To Find Its Footing In Crowded Oncology Space (NASDAQ:PBYI) | Seeking Alpha Puma Biotech Stock Struggles To Find Its Footing In Crowded Oncology Space (NASDAQ:PBYI) | Seeking Alpha](https://static.seekingalpha.com/uploads/2021/4/25/saupload_U22pq7urChUehpbRybf77rsWHgCPpfVvXu7oYf2ZN_d-7JloxsNAgsVg2jM83Fu9d9wZ7AeHZ50Z_aaZx0fQvHiIqA2Wer-bij4NvomBpxAl7EoVzrz6xGcE-wQGAkMHlYvVY4Rd.png)
Puma Biotech Stock Struggles To Find Its Footing In Crowded Oncology Space (NASDAQ:PBYI) | Seeking Alpha
![Price-Forecasting Models for Puma Biotechnology PBYI Stock: Ta, Ton Viet: 9798457684041: Amazon.com: Books Price-Forecasting Models for Puma Biotechnology PBYI Stock: Ta, Ton Viet: 9798457684041: Amazon.com: Books](https://m.media-amazon.com/images/I/618WvzgM8fL._AC_UF1000,1000_QL80_.jpg)